Diagnostic and therapeutic medical technology company Laborie Medical Technologies (Laborie) has introduced a new wireless pH-capsule reflux testing system, dubbed alpHaONE.

The alpHaONE system is intended as a diagnostic system for gastroesophageal reflux disease (GERD).

Providing up to 96 hours of monitoring data, the system aims to expand the company’s gastroenterology motility and reflux portfolio.

Laborie’s GI business unit sales and marketing vice-president Rhett Klein said: “alpHaONE is a patient-centric system that allows for comfortable monitoring and accurate, reliable data, fulfilling the needs of both patients and healthcare providers to diagnose GERD.

“Our primary objective has always been to provide solutions that elevate patient outcomes and enhance their overall experience and we look forward to launching this product.”

The device has a compact design and includes enlarged buttons. A fail-safe capsule delivery system is also incorporated into the device to protect the patient’s oesophagus.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The system is installed with a software application that features a virtual instruction programme to enable easy navigation.

Furthermore, Laborie has incorporated user-customisable symptom buttons and automatic pH data analysis to enhance the device user’s experience.

The alpHaONE system will be exhibited at the Digestive Disease Week (DDW) event in Chicago, Illinois, US, next month.

Based in Portsmouth, New Hampshire, Laborie produces diagnostic and therapeutic products for urology, urogynecology, obstetrics, gastroenterology, gynaecology and neonatal health applications.